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Eukaryotic cell culture presents metabolic engineers with opportunities not found in 
bacterial systems.  The cell cycle enables higher order organisms to continually check 
their growth conditions, taking internal inventory of their general metabolic state 
before committing to DNA replication or cell division.  Cell cycle check points and 
growth stimuli comprise an intricate feedback loop.  Similarly, insulin signaling 
works to insure cells do not overproliferate when taking advantage of nutrient 
availability within a developing multicellular organism.  However, the insulin 
signaling pathway is present in Drosophila S2 cells as well as whole flies, and may 
control growth in cell culture.  The work described here exploited the insulin 
signaling pathway and the cell cycle for enhanced cell growth and heterologous 
protein expression. By using the relatively new approach of RNA interference 
(RNAi) gene silencing, key intermediates involved in growth and cell cycling were 
interrupted.  This work demonstrates both the potential of RNAi and the utility of 
  













METABOLIC ENGINEERING OF EUKARYOTIC SIGNAL TRANSDUCTION IN 













Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 













Professor William Bentley, Chair 
Assistant Professor Adam Hsieh 
Professor Siba Samal  
Professor Nam Wang 
























© Copyright by 























 I would like to thank the many people who have made this work possible.  
These include my labmates in the Bentley lab, my committee members, teachers in 
Chemical Engineering and the Center for Biosystems Research (CBR), and the staff 
members of Chemical Engineering, Bioengineering (Julie Holbrook), and CBR. 
 I also want to thank my advisor, Bill Bentley who served both as catalyst and 
quench, as the moment required.  His ability to guide without pushing has endeared 
him to many of his former students, and I am honored to count myself among them.  
Throughout my time here he provided consent when the time was right, and advice 
with very generous support when it wasn't. 
 Finally, I want to give my loving thanks to my wife, Anne, to whom this work 
is dedicated.  Working a fulltime job to keep her husband in graduate school for most 
of our marriage is a task that will go largely unsung (at least in print) outside of these 
pages.  Her support of me and our family has been not only the reason for this work's 
completion, but the inspiration that made completing it a pleasure.  She would lift my 
spirits through months of bad data and raise a glass with me when results finally came 
in.  I cannot express gratitude and love enough to match my heart, but will suffice it 










Dedication ..................................................................................................................... ii 
Acknowledgements...................................................................................................... iii 
Table of Contents......................................................................................................... iv 
List of Figures .............................................................................................................. vi 
Chapter 1: Introduction ................................................................................................. 1 
Summary ................................................................................................................... 1 
Literature review....................................................................................................... 3 
Drosophila S2 cells ............................................................................................... 3 
Growth in Drosophila cells ................................................................................... 4 
Drosophila cell cycle........................................................................................... 10 
Protein expression and the cell cycle .................................................................. 16 
Double-stranded RNA interference .................................................................... 18 
Hypothesis............................................................................................................... 20 
Chapter 2: Insulin Stimulates Uptake of dsRNA by Drosophila Cells ...................... 22 
Introduction............................................................................................................. 22 
Materials, Methods and Results.............................................................................. 23 
Acknowledgements................................................................................................. 25 
Chapter 3: Engineering Eukaryotic Signal Transduction with RNAi: Enhancing 
Drosophila S2 Cell Growth via TSC1 ........................................................................ 26 
Abstract ................................................................................................................... 26 
Introduction............................................................................................................. 27 
Materials and Methods............................................................................................ 31 
Cell culture.......................................................................................................... 31 
dsRNA synthesis and transfection ...................................................................... 32 
Differential display (semi-quantitative RT-PCR)............................................... 33 
Western blot analysis .......................................................................................... 34 
Results and Discussion ........................................................................................... 34 
Insulin effects on growth .................................................................................... 34 
Tsc1 expression and inhibition ........................................................................... 38 
Acknowledgements................................................................................................. 45 
Chapter 4: Increasing protein yield through metabolic engineering of signal 
transduction and cell cycling in Drosophila S2 cells.................................................. 46 
Abstract ................................................................................................................... 46 
Introduction............................................................................................................. 47 
Materials and Methods............................................................................................ 50 
Cell culture, stable cell line, and induction......................................................... 50 
dsRNA synthesis and transfection ...................................................................... 51 
Differential display (semi-quantitative RT-PCR)............................................... 53 
FACS analysis..................................................................................................... 54 
Western blot analysis .......................................................................................... 55 




Gene silencing..................................................................................................... 55 
Physiological effects of silencing ....................................................................... 59 
Recombinant protein expression......................................................................... 64 
Tuning CycE transcription...................................................................................... 68 
Acknowledgements................................................................................................. 73 
Chapter 5:  Conclusions .............................................................................................. 74 
Insulin effects on physiology and dsRNA uptake................................................... 74 
TSC1 expression and effect on cell growth ............................................................ 75 
Insulin and cell cycling targets effect on recombinant protein synthesis ............... 75 








List of Figures 
Figure 1. ........................................................................................................................ 6 
Figure 2. ...................................................................................................................... 14 
Figure 3. ...................................................................................................................... 25 
Figure 4. ...................................................................................................................... 35 
Figure 5. ...................................................................................................................... 37 
Figure 6. ...................................................................................................................... 39 
Figure 7. ...................................................................................................................... 41 
Figure 8. ...................................................................................................................... 43 
Figure 9. ...................................................................................................................... 44 
Figure 10. .................................................................................................................... 58 
Figure 11. .................................................................................................................... 62 
Figure 12. .................................................................................................................... 63 
Figure 13. .................................................................................................................... 66 





Chapter 1: Introduction 
Summary 
 Recombinant protein production has emerged as a major component of the 
pharmaceutical industry (Thayer 2002).  The recombinant product fraction of the 
pharmaceutical market is expected to increase as the world population ages and new 
products, such as cosmetic proteins, come online (Class, 2002; Mullin, 2003).  
Enzymes are used to manufacture specialty chemicals, such as stereo-specific 
isomers, in addition to pharmaceuticals (Panke and Wubbolts 2002; Zhao et al. 2002).  
There are now more products than ever produced through recombinant means.  The 
increase in product lines has attracted the interest of greater numbers of 
manufacturers into the recombinant protein market.  With patents running out on as 
much as $13 billion worth of recombinant products in the next five years, generic 
manufacturers are entering the market (Rouhi 2002).  With more products and 
competition, there will be increased pressure for chemical producers to reduce 
production costs.   
 The most commonly used organism for synthesizing recombinant proteins is 
Escherichia coli (Lee 1996).  E. coli is inexpensive to grow, simply transformed, and 
genetically well-characterized.  Its use is well documented in the literature and will 
not be discussed here.  A limitation with E. coli is that it lacks the eukaryotic protein 
processing machinery to properly fold, glycosylate, and amidate many mammalian 
proteins.  This shortcoming has resulted in the necessity to use mammalian cell 




big for E. coli to produce effectively.  Mammalian cell culture can be far more 
expensive than E. coli fermentations, largely due to slower growth, increased genetic 
complexity, difficulties with transfection, and lower product yield.   
 One potential solution to producing high-quality, properly-processed 
mammalian (and other eukaryotic) proteins is to use Drosophila Schneider 2 (S2) 
cells.  S2 cells are a stable cell line derived from embryos of Drosophila 
melanogaster (Schneider 1972).  They grow more quickly in culture than mammalian 
cells and grow optimally at room temperature (25 to 28 °C)(Echalier 1997). The use 
of S2 cells for the production of recombinant gene products has been well-established 
(Kirkpatrick and Shatzman 1999).  They are almost as genetically well-characterized 
as E. coli (Adams et al. 2000), and it has been demonstrated that Drosophila cell 
cultures are capable of properly glycosylating and amidating mammalian proteins 
(Aldecoa et al. 2000; Benting et al. 2000; Li et al. 1996; Percival et al. 1997; Tota et 
al. 1995).  Some of the disadvantages of using S2 cells are that they grow more 
slowly, require greater care, and are more difficult to transfect than E. coli.  S2 cells 
also have a lower product yield (g product/L culture volume) than E. coli, which can 
have in excess of 10-fold higher yield than S2 cells (Lee 1996; Olsen et al. 1992; 
Pfeifer et al. 2001).   
 The work proposed here will address S2 cell growth and protein production. 
Specifically, it relates Drosophila cell growth, cycling, and proliferation regulation to 
recombinant protein production.  The focus is on the insulin signaling pathway and 






Drosophila S2 cells 
Drosophila melanogaster Schneider 2 cells were first isolated in 1972 at the 
Walter Reed Army Institute of Research in Washington, DC (Schneider, 1972).  The 
strain was developed from trypsinized fragments of 20 to 24-hour old Oregon-R 
Drosophila melanogaster embryos.  The cells can grow as a loosely attached 
monolayer in petri plates or in suspension.  The cell size can range from 5 to 10 m 
in diameter for round cells and up to 35 m in length for elongated cells, depending 
on the growth conditions.  Tetraploid cells compose approximately 60% to 80% of 
the culture, with all cells exhibiting XX (female) chromosomes (Echalier, 1997).   
 S2 cells are among the most frequently used Drosophila cell lines (Echalier, 
1997).  They can be modified to express various biopharmaceuticals and recombinant 
products, including many mammalian proteins (Lee et al. 2000; McCarroll and King 
1997).  However, S2 cells do not grow as quickly as E. coli and are more difficult to 
transfect.  This places S2 cells somewhere between mammalian cells and E. coli in 
their usefulness for large-scale production of recombinant proteins.  Recently, Lee 
and coworkers (2000) demonstrated that baculovirus–mediated transfection of S2 
cells for the production of enhanced green florescent protein increased transfection 
efficiency from 10% to nearly 100%.  The transfection left the cells in tact and 
increased the specific protein expression levels (as a fraction of total protein) to well 
within the range expressed by high five cells (a lepidopterin insect cell line) (Lee et 
al., 2000).  No follow-up work has been published on this approach, and no specific 




yet to be a study reviewing S2 cell growth with respect to recombinant protein 
production.     
Growth in Drosophila cells 
Two primary pathways have been the focus of studies investigating growth 
control in S2 cells: the insulin signaling pathway and the Ras-MAP kinase pathway.  
The positive effect of insulin on cell growth and proliferation have long been 
established (Mosna 1981; Mosna and Barigozzi 1976; Seecof and Dewhurst 1974; 
Wool et al. 1966; Wyss and Bachmann 1976).  The insulin signaling pathway (Fig. 1) 
is controlled both by the presence of insulin-like growth factors and nutrients 
(Brogiolo et al. 2001; Gao et al. 2002; Thomas and Hall 1997).  Its function in 
eukaryotes is to maintain balance between cell growth and available substrate.  
Insulin signaling is found in almost all eukaryotic organisms, and provides cells with 
a mechanism for halting growth in the absence of nutrients and for stimulating growth 
in times of excess nutrient availability.  Alterations in any component of the insulin 
pathway in Drosophila can affect either cell size or proliferation (Potter and Xu 
2001), but do not necessarily affect both (Verdu et al. 1999).  
The insulin signaling cascade starts with insulin or an insulin-like-peptide 
(Brogiolo et al., 2001).  There are at least seven known insulin like peptides in 
Drosophila (Claeys et al. 2002).  These peptides all stimulate the insulin receptor (Inr, 
a receptor tyrosine kinase) leading to the downstream activation of Akt, a protein 
serine/threonine kinase.  The Inr, while nominally a tyrosine kinase, cannot initiate 




receptors, Inr requires the help of a scaffolding adapter molecule known as an insulin 
receptor substrate (IRS, Chico in Drosophila).  Chico acts as a docking site for 
Drosophila dp110 (P13K in mammals), which in turn activates downstream cascades 
leading to both cell proliferation  and cell growth (Brogiolo et al. 2001; Claeys et al. 






Insulin and cell cycling pathway.  Insulin or nutrients stimulate the insulin receptor 
(Inr) on the cell membrane.  Phosphorylation of Inr (a tyrosine kinase-like receptor) 
leads to phosphorylation of the insulin receptor substrate, Chico.  Chico has numerous 
downstream phosphorylation targets, including dp110.  Nutrient or insulin stimulation 
leads to phosphorylation of dS6K, which has numerous downstream transcriptional 
and translational targets that stimulate growth, which shortens G1 of the cell cycle by 
(in part) synthesizing Cyclin E.  Rapidly growing cells become overproliferative 



























The Akt branch of the insulin pathway has been the subject of numerous 
studies.  The Akt pathway is linked to cell growth and proliferation control in whole 
fruit flies (Brogiolo et al. 2001; Claeys et al. 2002; Ito and Rubin 1999; Kozma and 
Thomas 2002; Miloloza et al. 2000; Oldham et al. 2000; Potter and Xu 2001; 
Radimerski et al. 2002; Rintelen et al. 2001; Soucek et al. 1997; Stocker and Hafen 
2000; Tapon et al. 2001a; Tapon et al. 2001b), but the phenotypic effects of 
alterations to this pathway have not been studied in S2 cells.  For example, Clemens 
and coworkers demonstrated that dsRNA (double stranded RNA interference) 
inhibition of DPTEN (Drosophila phosphatase and tensin homologue deleted from 
chromosome 10) results in a 19-fold increase in Akt activity in S2 cells in the 
presence of insulin, but never studied cell growth or morphology in the DPTEN 
knock-outs (Clemens et al. 2000; Leff 2001).  By preventing Akt phosphorylation, 
DPTEN stimulates forkhead transcription factor translocation to the nucleus.  When 
in the nucleus, the forkhead transcription factors activate transcription of cyclin-
dependent kinase inhibitors (such as p27Kip1), which inhibit Cyclin E/Cdk2 activity 
in Drosophila. The result is G1 cell cycle arrest (Nakamura et al. 2000) and possibly 
reduced cell proliferation. 
Verdu and coworkers found that overexpression of dp110 (P13K) and Akt in 
whole flies results in increased cell size, but no increase in cell number (Verdu et al. 
1999).  However, inhibition of DPTEN has been shown to increase cell growth and 
proliferation in Drosophila whole flies (Gao et al. 2000).   DPTEN mutant fly eye 
cells outgrew their non-mutated counterparts three to one, and were 140% larger.  




driver proved fatal for the most part, with those that survived exhibiting severely 
limited growth (Gao et al., 2000).  This suggests that there may be an independent 
pathway or branch point downstream of DPTEN, independent of Akt that is 
responsible for proliferation.  
An important control point in the insulin pathway occurs with the protein 
TOR (target of rapamycin) and its interaction with the gene product of gigas.  Gigas 
is the Drosophila homologue of tubular sclerosis gene 2 (TSC2) in mammals.  In 
mammals and Drosophila, the TSC2 gene product, tuberin, forms a complex with 
hamartin, the product of tubular sclerosis gene product 1 (TSC1) (Ito and Rubin 
1999).  When active, the complex antagonizes the insulin signaling pathway by 
blocking TOR phosphorylation (Ito and Rubin 1999).  Human mutants of TSC1 or 
TSC2 develop tubular sclerosis, a disease marked by benign tumor cells called 
hamartomas, giant–sized cells in the tumorous tissue (Ito and Rubin 1999). The effect 
of TSC1 or TSC2 inhibition in whole flies and mammalian cells is the same, 
specifically that cells grow two to four times normal size and overproliferate (Aicher 
et al. 2001; Ito and Rubin 1999; Miloloza et al. 2000; Potter et al. 2002; Potter and Xu 
2001; Soucek et al. 1997; Tapon et al. 2001b).  Akt phosphorylation regulates the 
TSC complex (Aicher et al., 2001), and aids it in its role as a tumor suppresser.  
When phosphorylated by Akt, tuberin disassociates from hamartin (Potter et al., 
2002) and loses its ability to limit TOR activity (Gao et al., 2002).   
Gao and coworkers found that reducing expression of TOR by 50% recovered 
the effect of inhibiting TSC gene expression (i.e. increased cell size) in Drosophila 




regulates TOR activity, downstream products of TOR were measured (rather than 
TOR itself) due to the unavailabilty of antibodies specific to Drosophila TOR.  
dsRNA against TSC1 or TSC2 resulted in a 4.5-fold increase in S6K phosphorylation, 
without a change in the S6K protein levels.  dsRNA against TOR had the same effect, 
regardless of whether dsRNA against TSC genes were used.  Further, 
immunoprecipitation experiments revealed that tuberin (the TSC2 gene product) 
interacted with TOR in vivo.  Taken together these results indicated the that TSC gene 
products regulate TOR expression and control of the Akt signaling pathway (Gao et 
al., 2002).   
TOR has been linked to amino acid sensing (Hara et al. 2002; Miron and 
Sonenberg 2001) as well as to the insulin cascade (Gingras et al. 2001; Miron and 
Sonenberg 2001). Insulin stimulates muscle growth (Wool et al. 1966; Wyss and 
Bachmann 1976), but there is evidence that a significant portion of muscular growth 
following amino acid starvation stems from the amino acids themselves, independent 
of insulin (Svanberg et al. 1996).  Hara and coworkers investigated S6K and eIF-4E 
BP1 phosphorylation in mammalian cell lines in response to amino acid abundance 
(Hara et al. 1998).  They determined that there existed an unknown factor between 
TOR and extracellular amino acids that downregulated TOR activity in the event of 
amino acid depravation (Hara et al., 1998).  The effect was seen regardless of the 
presence of insulin.  The unknown factor that senses amino acids may be the TSC 
complex.  Through its interactions with TSC gene products, TOR senses extracellular 
amino acid concentrations and up regulates translational initiation regulators such as 




acids (Gao et al., 2002; Miron and Sonenberg, 2001).  The mechanism by which the 
TSC complex senses amino acid concentrations is unknown.  It may be the case that 
the TSC complex prioritizes stimuli such that amino acid starvation closes the insulin 
pathway, and restoration of amino acids allows insulin-mediated growth.  The work 
of Hara and others supports this hypothesis.  In the presence of insulin and the 
absence of amino acids, S6K was not phosphorylated.  The amino acid concentration 
required to restore S6K activity was four times lower in insulin-stimulated cells than 
in non-stimulated cells (Hara et al., 1998). 
Drosophila cell cycle 
In order to understand eukaryotic cell growth and proliferation, researchers 
have long focused on the cell cycle.  There is a link between the cell cycle and cell 
growth and proliferation (Tapon et al. 2001b). In higher order organisms such as 
Drosophila, the developmental stage of the organism as well as the organ or system 
in question play important roles in how the cell cycle relates to cell growth.  In 
Drosophila embryos, cells divide rapidly without growing as a result of a shortened 
cell cycle.  In eye imaginal disks cells grow to five or six times their post-mitotic size 
before dividing (Tapon et al. 2001b).       There are some factors, such as cyclins, 
which are synthesized in close correlation with cellular growth that are responsible 
for at least some aspects of cell cycle progression (Bock et al. 2001). Weigmann and 
coworkers, working with Drosophila pupal imaginal disc cells, demonstrated that cell 
size is not controlled by factors effecting cell division, but rather by "physical 
distance or tissue volume", which could be interpreted as volumetric concentrations 




discs mutant for Cdc2 where arrested in G2 of the cell cycle, the resultant wing size 
was the same as a non-mutated control, but the size of the cells in the wing were 
much larger, indicating that growth can proceed in the absence of cell division 
(Weigmann et al., 1997).  
Factors that control the Akt or Ras pathways also control, either directly or 
indirectly, the synthesis and activation of cell cycle regulators (Tapon et al. 2001b).  
Reducing function in any of the insulin pathway components Chico, dp110, DPTEN, 
Akt, TOR, PDK-1, or SK6 slows the cell cycle (Oldham et al. 2000; Stocker and 
Hafen 2000).  The exact pathways are unclear, but Myc, a protein long associated 
with cell proliferation and death (Coller et al. 2000) also has a strong effect on the 
cell cycle (Nasi et al. 2001).  Induction of Myc expression shortened G1, but caused a 
concomitant lengthening of G2 in Drosophila developing wings (Johnston et al. 
1999).  Cells overexpressing Myc were smaller than wild-type controls and grew 
poorly (Johnston et al., 1999).  For its role in shortening G1, Myc is thought to 
increase Cyclin E activity.  Increasing dp110 or Ras expression increased growth 
rates, but did not accelerate the cell cycle in Drosophila imaginal discs (Bock et al., 
2001).   
Some cyclin-containing factors such as the cyclin-independent kinase 4 
(CDK4)/Cyclin D complex, which drive cell growth, do not have a direct effect on 
cell cycling (Datar et al. 2000; Meyer et al. 2000).  Datar and coworkers 
demonstrated that overexpression of Cyclin D/CDK4 resulted in Drosophila eye 
overgrowth and increased proliferation without changing the cell cycle (Datar et al., 




proliferation with no significant change in cell size.  Sixty-seven hours after induction 
of Cyclin D/CDK4 overexpression the wing cells filled an area that was 180% of the 
area occupied by the controls.  In the same study it was shown that Cyclin E 
overexpression truncates G1 and decreases cell size.   
Cyclin E plays an important role in G1 to S phase transition, but that role is 
not completely understood (Bock et al. 2001; Richardson et al. 1993).  Lees and 
others determined that Cyclin E aids in regulating the tumor suppresser gene, 
retinoblastoma, which forms a complex with transcription factor E2F and cyclin E 
during G1 (Lees et al. 1992).  Cyclin E-mediated phosphorylation inactivates 
retinoblastoma and allows the cells to pass to S phase (Richardson et al., 1993). 
Cyclin E levels are controlled, in part, by ubiquitin-mediated proteolysis.  
Accumulation of Cyclin E can result in premature S phase entry, genetic instability, 
and tumorigenesis (Koepp et al. 2001).  Destruction of Cyclin E is a function of the 
26S proteasome, and is facilitated by the formation of polyubiquitin-protein 
conjugates.  A ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme 
(E2), and Archipelago, a ubiquitin ligase (E3) are involved in a cascade of reactions 
that ultimately form a ubiquitin complex with Cyclin E, marking it for proteolysis 
(Fig. 2A).  Archipelago-mutant Drosophila eye cells have elevated levels of Cyclin E 
and overproliferate (Moberg et al. 2001).  Moberg and coworkers successfully 
inhibited Archipelago synthesis in S2 cells by transfecting cells with dsRNA against 
ago, the gene encoding Archipelago (Moberg et al., 2001).  They did not examine the 
phenotypic effects of the transfection on S2 cells.   Hence, it has already been 




accumulation, and that Cyclin E accumulation can lead to overproliferating cells in 
flies. The three elements have not previously been coordinated or examined as a 






Growth stimulus and the cell cycle. A. Many factors stimulate transcription of key 
signaling molecules, such as Cyclin E.  Cyclin E accumulation triggers G1 to S phase 
transition.  Archipelago (Ago) tightly regulates Cyclin E via ubiquitination and 
proteolysis (26S proteosome).  Three enzymes serve to ubiqinate numerous proteins 
for proteolysis, a ubiqutin activating enzyme (E1), a ubiquitin conjugating enzyme 
(E2), and a ubiquitin ligase (E3), which is archipelago (Ago) in the case of cyclin E.  
B.  Proposed model of Tapon, et. al (2001), in which disparate stimuli control the 
anabolic landscape in favor of protein, carbohydrate, or lipid synthesis.  Growth 
factor A favors protein synthesis, while growth factor B stimulates lipid synthesis.  







































































Protein expression and the cell cycle 
 Cell growth and protein expression can vary significantly throughout the life 
of a cell culture.  Creanor and coworkers estimated that yeast cells exhibited an 
increase in protein expression rates for the first 60% of the cell cycle when compared 
to the remaining 40% (Creanor and Mitchison 1982).  The cell cycle phases have 
numerous overlapping qualities, but in general, G1 is for cell growth and, 
presumably, protein synthesis.  The G1 phase can be divided into two subphases: the 
post-mitotic phase (G1pm) and the pre-synthesis phase (G1ps) (Abu-Absi and Srienc 
2000).  In G1pm the cell is dependent upon growth factors, and requires growth 
before it can proceed with the rest of the cell cycle.  When the cell is prepared to 
begin replicating the DNA and continue with the cell cycle it is in G1ps, which is 
delineated from G1pm by the restriction point (Abu-Absi and Srienc, 2000). 
Tapon and colleagues (2001) proposed a simple model for the disparate 
growth stimuli on the cell cycle and anabolic pathways (Fig. 2B). In short, there may 
be a stimulus that prolongs G1, resulting in heightened protein synthesis, or prolongs 
G2/M, resulting in the production of more lipid.  These scenarios are meant to 
illustrate that there may exist distinct metabolic states which are more amenable to 
specific target-compound synthesis. 
 Cells growing in culture are subject to various stresses, including oxidative 
stress, heterologous protein expression, shear stress, toxin buildup and nutrient 




which has overlapping control pathways with the cell cycle (Fussenegger and Bailey 
1998).  In addition to changing environmental parameters such as nutrient 
concentrations and impeller speed, approaches to minimizing apoptosis include 
overexpression of anti-apoptotic genes and injection of chemical antagonists to 
apoptotic pathways.  The gene product of bcl-2, a mammalian survival gene, inhibits 
apoptosis and has been used to increase yield of monoclonal antibody by up to 40% 
in chemostat cultures of hybridoma cells (Simpson et al. 1997).  By adding thymidine 
to cells expressing bcl-2, apoptosis was suppressed longer than without the thymidine 
addition (Singh et al. 1996).  Cells respond to amino acid starvation by inhibiting the 
insulin signaling cascade, limiting protein translation, and initiating apoptosis.  
 Mazur and coworkers demonstrated the use of controlled proliferation in the 
production of secreted alkaline phosphatase (SEAP) in Chinese hamster ovary (CHO) 
cells (Mazur et al. 1998).  Cells grew until they reached early stationary phase and 
then were induced to synthesize SEAP concurrently with the p27 gene product.  P27 
is a mammalian cell-cycle-arresting gene, which allowed the cells to remain in G1 of 
the cell cycle.  This approach is similar to that used frequently in bacterial 
fermentations for anaerobic fermentation products.  There, cells are grown aerobically 
to an optimum density and then allowed to synthesize products anaerobically, with 
very little cell growth. The biphasic approach for eukaryotic systems takes advantage 
of cell cycle controls to achieve the same stationary state exhibited in bacterial 
fermentations.  By using a tetracycline-dependent promoter, Mazur and coworkers 
coordinated G1 rest with optimal cell density.  Tetracycline degraded (with or without 




concentration of 20 ng/mL, the concentration of tetracycline in the media was low 
enough after 48 hours to prevent promoter inhibition.  With tetracycline below the 
threshold value, the promoter allowed for synthesis of p27 and SEAP concurrently.    
The result was a 15-fold increase in SEAP expression in biphasic cells over 
proliferation competent controls (Mazur et al., 1998).  Biphasic protein expression 
control has not yet been demonstrated in S2 cells.  Although S2 cells have a cell cycle 
distinct from mammalian cells, they still have a presumed increase in protein 
synthesis in G1pm, and are subject to similar stresses in expressing heterologous 
proteins (Echalier, 1997). 
Double-stranded RNA interference 
 In 1998, Fire and coworkers reported on the use of short sequences of double-
stranded RNA for interfering with gene expression in Caenorhabditis elegans (Fire et 
al. 1998b).  The method has since been used in fungi, plants, fish, and Drosophila 
among other organisms (Fire 1999; Ullu et al. 2002).  The mechanism by which 
dsRNA inhibits gene expression is not entirely known, but the most generally 
accepted model can be described as follows.  Short sequences of double-stranded 
RNA enter the cytoplasm of a cell, either by injection or diffusion, where they are 
cleaved by an enzyme (Dicer in Drosophila) or enzyme complex to 22 nucleotide 
RNA fragments with short 3' overhangs.  The fragments then find and bind to the 
mRNA to which they are homologous.  This step likely takes place on the cleaving 
enzyme, which is thought to posses a helicase domain.  Once the mRNA and short 
dsRNA fragment are bound, the cleavage enzyme degrades the mRNA, rendering it 




 dsRNA is an effective tool for  targeted inhibition of specific gene expression 
in S2 cells (Caplen et al. 2000; Clemens et al. 2000).  Clemens and coworkers used 
dsRNA to investigate the insulin-signaling pathway.  By inhibiting expression of 
Chico, DPTEN, and dp110, researchers confirmed the order of these components in 
the insulin pathway and demonstrated the use of dsRNA is S2 cells.  Similarly, 
Caplen and coworkers demonstrated dsRNA efficacy against heterologous protein 
expression in S2 cells (Caplen et al., 2000).  In transient and stable transfections, 
green-fluorescent-protein-specific dsRNA inhibited green fluorescent protein (GFP) 
expression without interfering with expression of the recombinant control product, 
chloramphenicol acetyltransferase (CAT).  While the inhibition was not as 
pronounced as it was in the Clemens study, it demonstrated the very specific nature of 
the knockout.  These two examples are likely only a small fraction of the studies 
using dsRNA to investigate gene expression in S2 cells currently being undertaken.  
The technology is simple to use and can theoretically be targeted against any gene 
expressed in S2 cells.  
 Recent work has focused on in vivo synthesis of double-stranded (dsRNA) or 
short interfering RNA (RNAi) in Drosophila (Giordano et al. 2002), plants (Wesley 
et al. 2001), and mammalian cells (Brummelkamp et al. 2002).  RNAi usually refers 
to the in vivo synthesis of dsRNA with homology to a target mRNA.  The length of 
the dsRNA is sometimes only 22 nucleotides, the same size that larger dsRNA is 
believed to be fragmented into.  While short, interfering RNA is effective in 
mammalian systems, it has been demonstrated that in S2 cells larger (>500 nt) 




flies Giordano and coworkers expressed dsRNA against white, a color marker in 
Drosophila eyes, using the pUAST vector to express sense and antisense strands of 
white under GAL-4 UAS promoter (Giordano et al., 2002).  Sense and antisense 
strands synthesized under the same promoter were expected to anneal to form the 
dsRNA.  It was estimated by the researchers that the sense and antisense strands did 
not anneal as readily as had been expected, and therefore the construct was less 
efficient of a tool for gene inactivation than a similar construct carrying inverted 
repeats of white with 200 bp spacing between them.  In both constructs white mRNA 
was diminished, however, the effect was more pronounced in the case of the inverted 
repeats.  The use of in vivo dsRNA synthesis has not yet been demonstrated in S2 cell 
culture. 
Hypothesis 
 The work described above regarding Drosophila growth, proliferation, and 
cell cycle regulation has demonstrated that inhibition or overexpression of certain key 
factors in Drosophila can change cell size, proliferation, and cell cycling.  More 
specifically, inhibition of the insulin pathway regulators, DPTEN and TSC1 result in 
overgrowth and overproliferation of Drosophila imaginal discs.  Inhibition of Cyclin 
E results in cell cycle arrest in Drosophila.  Inhibition of Archipelago synthesis 
results in accumulation of Cyclin E.  There is a potential link between amino acid 
availability and insulin signaling that may implicate the TSC complex as the central 
component to both pathways. 
 The amino acid signaling pathway and the insulin signaling pathway, which 




(Conlon et al. 2001; Oldham et al. 2000).  As cells grow in G1pm (under the 
influence of the insulin pathway), they synthesize Cyclin E.  When Cyclin E reaches a 
threshold concentration (up to eight times its mitotic level), the cells can enter S 
phase (Richardson et al., 1993).  These observations give potential targets for 
metabolic engineering through both up- and down-regulation.   
 The hypothesis for this work was as follows: 
1. Inhibition of DPTEN, TSC1, and ago will result in increased S2 cell proliferation 
and protein synthesis. 
2. S2 cells that are enhanced for growth and proliferation will reach early stationary 
phase sooner than cells that have not been enhanced as described in 1. above. 
3. S2 cells can be maintained in G1 of the cell cycle by inhibiting Cyclin E 
expression.   
4. S2 cells maintained in G1 will synthesize recombinant protein at a faster rate and 










The advent of RNA interference has facilitated a boom in biochemical 
pathway analysis, and functional genomics.  RNAi refers to any RNA molecule that 
interferes with the expression of its homologous gene product (Fire et al. 1998a; 
Rocheleau et al. 1997; Timmons and Fire 1998). Also referred to as post-
transcriptional gene silencing, RNAi is exquisitely specific for the targeted gene and 
encompasses sense, antisense, or double-stranded RNA (dsRNA) molecules, although 
it is commonly attributed with dsRNA as single-stranded RNA (ssRNA) effects have 
been traced to low levels of contaminating dsRNA (Fire et al. 1998a; Rocheleau et al. 
1997).   
Double-stranded RNA of 220 to 700 basepairs has been shown to significantly 
reduce levels of mRNA transcript in Drosophila cell culture for a wide range of genes 
including insulin signaling pathway components (Clemens et al. 2000), recombinant 
GFP (Caplen et al. 2000), and for 91% of the genes associated with proliferation and 
survival (Boutros et al. 2004). Double-stranded RNA of 500 to 700 basepairs can be 
transfected into Drosophila Schneider 2 (S2) cells by incubating them with fetal 
bovine serum (FBS) following serum starvation (Clemens et al. 2000).  
Unfortunately, FBS has numerous stimulatory effects and can greatly complicate 




Materials, Methods and Results 
 
We were able to remove FBS completely from dsRNA studies by replacing it 
with porcine insulin.  To test the effect of trying to replace FBS with insulin, we 
selected Cyclin E as a target gene for silencing. S2 cells were grown in Drosophila 
serum-free media (SFM) (Invitrogen, Carlsbad, CA).  Double-stranded RNA was 
synthesized following a modified version of the method developed by Clemens and 
coworkers (Clemens et al. 2000).  Briefly, S2 cells were grown to 5×106 cells/mL, 
and RNA was extracted using an RNAqueous® kit (Ambion, Houston, TX) 
according to the manufacturer’s protocol.  First strand templates of Cyclin E DNA 
were synthesized from the total mRNA using oligo-dT primers and a Retroscript® kit 
(Ambion) as per the manufacturer’s instructions.  A 630 basepair region of first strand 
DNA template was PCR amplified using Cyclin E specific primers (5’-ATG GGT 
TTA AAT GCC AAG AGT GTT TGT TC; 3’-CAC CAC CAC TGG CGT CTG CTT 
GCT TCC ACG.  T7 sequences (TAA TAC GAC TCA CTA TAG GGA) were added 
to each Cyclin E template using PCR, making T7 templates.  To transcribe single-
stranded RNA (ssRNA), T7 templates were used with the Megascript™ kit (Ambion) 
as per the manufacturer's instructions.  The ssRNA synthesized was extracted using 
phenol/chloroform and resuspended in nuclease-free water to a concentration of 
approximately 3.3 µg/µL.  Single-stranded RNA was incubated at 65 ºC for 30 
minutes before being allowed to cool to room temperature on the benchtop.  
Subsequent to this annealing step, dsRNA was checked for size and integrity using 




 Cells were seeded in triplicate to 1×106 cells/well in 0.7 mL SFM in 12-well 
plates and incubated with 15 µg/mL dsRNA against cyclin E, chloramphenicol acetyl 
transferase (CAT), or an equal volume of nuclease-free water.  CAT was used as a 
control because it has no significant similarity to any genes in the Drosophila genome 
(BLAST search).  The CAT dsRNA was 630 basepairs long.  After 1 hour incubation, 
SFM containing either 10% FBS (Sigma, St. Louis, MO) or 1.75 µM porcine insulin 
(Sigma) was added to a final volume of 2.1 mL per well.  The plates were incubated 
for 60 hours at 27 ºC.  RNA was extracted from the cells and RT-PCR was performed 
as described above for a 630-basepair segment of Cyclin E and a 866-basepair 
segment of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading 
control.  Each treatment's triplicate RNA samples were pooled before reverse 
transcription.  Results (Fig. 3) indicate that insulin worked as well or better than FBS 






Insulin stimulates uptake of dsRNA in S2 cells.  A.  RT-PCR of total RNA from S2 
cells using oligo-dT primers for reverse transcription, and Cyclin E-specific primers 
for PCR.  Conditions are listed across the top with cells either receiving dsRNA 
treatment against Cyclin E (dsCycE), CAT (dsCAT), or no dsRNA treatment 
(Nothing).  Either insulin or FBS was used to stimulate dsRNA uptake.  B.  Reverse 
transcripts were also subject to PCR using GAPDH primers as a loading control.  C.  
RT-PCR of total RNA from S2 cells using oligo-dT primers for reverse transcription, 
and TSC1-specific primers for PCR following treatment with nuclease-free water and 
no insulin (No Ins), nuclease free water and 1.75 µM insulin stimulation (No 
dsRNA), 6 µg/mL dsRNA against TSC1 (6-TSC1), 15 µg/mL dsRNA against TSC1 
(15-TSC1), 30 µg/mL dsRNA against TSC1, and 15 µg/mL dsRNA against dsRED 
(15-dsRED).  D.  Reverse transcripts were also subject to PCR using GAPDH primers 










Chapter 3: Engineering Eukaryotic Signal Transduction with 
RNAi: Enhancing Drosophila S2 Cell Growth via TSC1 
 
Abstract 
 RNAi has been useful in the study of biochemical pathways, but has not been 
widely used as a tool in metabolic engineering.  The work described here makes use 
of double-stranded RNA (dsRNA) for the post-transcriptional gene silencing of TSC1 
in Drosophila S2 cells.  TSC1 downregulates the insulin pathway, and serves as a 
metabolic control to guard against cellular overproliferation and tumorogenesis in 
both flies and mammals.  By silencing TSC1 with in vitro-synthesized dsRNA, we 
have created a tunable and specific metabolic “throttle” that apparently circumvents 
deleterious and pleiotropic effects of excess insulin addition (eg. which lead to lysis), 
while significantly increasing the specific growth rate of S2 cells in a dose dependent 
manner. During the period wherein dsRNA was active, cell growth rate was increased 
by 11 % by the addition of 15 µg/mL dsTSC1 and by over 20% by the addition of 
30µg/mL dsTSC1. Potential applications for improving eukaryotic cell culture are 
anticipated. 
 
Keywords: Drosophila, S2, Sl-2, cell culture, insulin, harmartin, TSC1, tubular 




Introduction   
The use of RNA molecules to inhibit gene expression is referred to as RNA 
interference (RNAi) or antisense RNA.  Antisense RNA refers to RNA that is single-
stranded, complimentary to a target sequence, and mostly used in prokaryotic 
organisms.  RNAi refers to either long (500-800 bp) or short (21-23 bp) fragments of 
double-stranded RNA that also inhibit complementary genes, although through a 
different mechanism, and exclusively in eukaryotes.    The specific and tightly 
regulated nature of RNAi has made it indispensable as a tool in the biological 
sciences, but RNAi has thus far found limited use in metabolic engineering, perhaps 
due to its transient nature (when syntheisized in vitro), relatively inefficient delivery 
methods in mammalian cell culture, and the more typical metabolic engineering 
objective functions based on permanent changes in genotype. Noteworthy examples 
of gene silencing in the metabolic engineering literature employing antisense RNA 
have appeared, however, resulting in the formation of novel glycosyltransferase 
regulators in CHO cells (Prati et al. 2002; Prati et al. 1998), increased yield of 
metabolites acetone and butanol in C. acetobutylicum (Desai and Papoutsakis 1999) 
and increased yield and activity of an organophosphorus hydrolase expressed in E. 
coli (Srivastava et al. 2000).  In the latter case, antisense RNA was used to 
downregulate the heat shock response during protein production and the desired 
transient effects were a result of the relative instability of ssRNA in E. coli.   
In eukaryotes with significantly longer process time constants (e.g. tissue or 
organism generation rate), and with different silencing mechanisms, single-stranded 




target genes in several organisms, including C. elegans (Fire et al. 1998a; Fire et al. 
1998b; Montgomery and Fire 1998; Sharp 1999), Drosophila (Caplen et al. 2000; 
Clemens et al. 2000; Matsushima et al. 2004; Misquitta and Paterson 1999), 
trypanosomes (Ngo et al. 1998), cultured mammalian cells (Krichevsky and Kosik 
2002; Sui et al. 2002; Xia et al. 2002), plants (Angell and Baulcombe 1997; Klahre et 
al. 2002; Voinnet and Baulcombe 1997; Voinnet et al. 1998) and mice (Xia et al. 
2002).  Importantly, it has been reported that dsRNA and antisense RNA directly or 
virally delivered to Lepidopteran insect and insect cells can suppress the expression 
of housekeeping genes such as Bmwh3 (B. mori white eye, (Quan et al. 2002), 
hemolin (H. cecropia hemolin, (Bettencourt et al. 2002) and JH esterase (H. virescens 
JH esterase, (Hajos et al. 1999). The recent emergence of in vivo RNAi synthesis 
techniques (Matsushima et al. 2004; Sui et al. 2002; Xia et al. 2002) will surely lead 
to an array of host functions that are stably suppressed to alter the protein synthesis 
landscape. 
Drosophila melanogaster Schneider 2 cells were first isolated in 1972 at the 
Walter Reed Army Institute of Research in Washington, DC (Schneider 1972).  The 
strain was developed from trypsinized fragments of 20 to 24-hour old Oregon-R 
Drosophila melanogaster embryos.  The cells can grow as a loosely attached 
monolayer in petri plates or in suspension.  The cell size ranges from 5 to 10 µm in 
diameter for round cells and up to 35 µm in length for elongated cells, depending on 
the growth conditions.  Tetraploid cells compose approximately 60% to 80% of the 
culture, with all cells exhibiting XX (female) chromosomes (Echalier 1997).  S2 cells 




be modified to express various biopharmaceuticals and recombinant products, 
including many mammalian proteins (McCarroll and King 1997).  S2 cells compare 
favorably with other expression systems in that they are simple to manipulate, 
genetically well characterized, and can grow without CO2 supplementation.   
One of the objectives for metabolic engineering of eukaryotic cell culture is to 
increase the specific growth rate of cells grown in suspension.  To this end, several 
media formulations used in industrial settings include insulin as a growth stimulant.  
The positive effect of insulin on cell growth and proliferation has long been 
established (Mosna 1981; Mosna and Barigozzi 1976; Seecof and Dewhurst 1974; 
Wool et al. 1966; Wyss and Bachmann 1976).  The insulin signaling pathway is 
controlled both by the presence of insulin-like growth factors and nutrients (Brogiolo 
et al. 2001; Gao et al. 2002; Thomas and Hall 1997).  Its function in developing 
eukaryotes is to maintain balance between cell growth and available substrate.  
Insulin signaling is found in almost all eukaryotic organisms, and can provides cells 
with a mechanism for halting growth in the absence of nutrients and for stimulating 
growth in times of excess nutrient availability.  Alterations in any component of the 
insulin pathway in adult Drosophila can affect either cell size or proliferation (Potter 
and Xu 2001), but do not necessarily affect both (Verdu et al. 1999).  
An important control point in the insulin pathway occurs with the protein 
TOR (target of rapamycin) and its interaction with the gene product of gigas.  Gigas 
is the Drosophila homologue of tubular sclerosis complex gene product 2 (TSC2) in 
mammals.  In mammals and Drosophila, the TSC2 gene product, tuberin, forms a 




Rubin 1999) (Fig 1).  When active, the complex antagonizes the insulin signaling 
pathway by blocking TOR phosphorylation (Ito and Rubin 1999).  Human mutants of 
TSC1 or TSC2 develop tubular sclerosis, a disease marked by benign tumor cells 
called hamartomas, giant–sized cells in the tumorous tissue (Ito and Rubin 1999). The 
effect of TSC1 or TSC2 inhibition in whole flies and mammalian cells is the same, 
specifically that cells grow two to four times normal size and overproliferate (Aicher 
et al. 2001; Ito and Rubin 1999; Miloloza et al. 2000; Potter and Xu 2001; Soucek et 
al. 1997; Tapon et al. 2001b).  Akt phosphorylation regulates the TSC complex 
(Aicher et al. 2001).  When phosphorylated by Akt, tuberin disassociates from 
hamartin (Potter et al. 2002) and loses its ability to limit TOR activity (Gao et al. 
2002).   
Gao and coworkers found that reducing expression of TOR in Drosophila 
eyes partially recovered mutations in TSC2 (Gao et al. 2002).  In order to ascertain 
whether the TSC complex regulates TOR activity, downstream products of TOR were 
measured (rather than TOR itself) due to the unavailabilty of antibodies specific to 
Drosophila TOR.  dsRNA against TSC1 or TSC2 resulted in a 4.5-fold increase in 
S6K phosphorylation, without a change in the S6K protein levels.  dsRNA against 
TOR had the same effect, regardless of whether dsRNA against TSC genes were 
used.  Further, immunoprecipitation experiments revealed that tuberin (the TSC2 gene 
product) interacted with TOR in vivo.  Taken together these results indicated that TSC 
gene products regulate TOR expression and control of the Akt signaling pathway 




Moreover, Kapahi and coworkers recently found that the TSC complex was 
linked to extension of lifespan in Drosophila.  They compared mutated flies to flies 
expressing TSC2 and TSC1 under the constitutive GAL4 promoter and found that 
overexpressing TSC2 and TSC1 extended lifespan beyond that of the mutated control 
by 12% and 14%, respectively (Kapahi et al. 2004).  To determine if nutrient 
stimulation had an effect on lifespan they fed the flies nutrient-rich media.  The 
lifespan of control flies was reduced in rich media, but overexpression of TSC2 
mediated the effects of nutrient stimulation.  According to the authors, TSC2 protects 
the cells from the deleterious effects of nutrient overstimulation by mimicking dietary 
restriction (Kapahi et al. 2004).  In effect, the TSC complex appears to keep cells 
from overreacting to positive growth stimuli.     
 This study investigated the use of dsRNA as a tool for metabolic engineering 
of S2 cells.  Specifically, the large and overproliferating cells noted by previous work 
inhibiting TSC1 function were attractive from our application-specific perspective: 
increased growth and potentially, protein synthesis.  Thus, we examined the effect of 
various growth conditions on TSC1 mRNA expression and tested whether in vitro-
synthesized dsRNA against Drosophila TSC1 could be used to increase the specific 
growth rate of S2 cells grown in shake-flask cultures.   
Materials and Methods 
Cell culture 
Drosophila melanogaster Schneider 2 (S2) cells were grown in Drosophila 
serum-free media (SFM) (Invitrogen, Carlsbad, CA) in 250 mL shake flasks at 27 ºC 




cells/mL to 3×107 cells/mL for all experiments.  Cell density was determined using a 
standard hemocytometer and trypan blue exclusion staining.  For dsTSC1 
experiments, a pulse of insulin was added to the shake flasks to a final concentration 
of 2.5 µM at 60 hours post-transfection.   
For insulin concentration experiments, insulin was added to the SFM media to 
final concentrations of 0.05, 0.25, 2.5, 5, 7.5 and 15 µM.  Each test was evaluated in 
at least duplicate flasks, each with duplicate measurements.   
For TSC1 expression experiments, cells were grown in 35 mm petri dishes and 
incubated (27 ºC) either with or without orbital shaking (50 rpm) overnight after 
supplementation with 2.5 µM insulin or an equal volume of nuclease-free water. 
dsRNA synthesis and transfection 
dsRNA was prepared following the method of Clemens et al. (2000).  Briefly, 
S2 cells were stimulated with bovine insulin (2.5 µM) to transcribe components of the 
insulin signaling pathway.  After 0.5 to 2 hours, RNA was extracted using an 
RNAqueous kit (Ambion, Houston, TX) according to the manufacturer’s protocol.  
First strand copy DNA (cDNA) templates of TSC1 were transcribed from the mRNA 
using OligodT primers and the Retroscript® kit (Ambion) as per the manufacturer’s 
instructions.  A 700 basepair region of TSC1 from the ATG start codon to 700 nt 
downstream was PCR amplified from first strand cDNA templates using the PCR 
MasterMix™ kit from Promega (Madison, WI) and TSC1 specific primers (5’-ATG 
ACG CTG GAG AAC GAG GAG GCC AAG CGC-3'; 3’-CCA TCT CCT TCC 
ATC GCG TAT TGT TTA CCT-5').  T7 templates were prepared from the TSC1 700 




CTA TAG GAT GAC GCT GGA GAA CGA GG-3'; 3’-TAA TAC GAC TCA CTA TAG 
GCC ATC TCC TTC CAT CGC G-5').  To make the dsRNA, T7 templates were used 
with the Megascript™ kit (Ambion) as per the manufacturer’s instructions.  The 
single-stranded RNA (ssRNA) synthesized was extracted using phenol/chloroform 
and resuspended in nuclease-free water to a concentration of approximately 3.3 
µg/µL.  ssRNA was incubated at 65 ºC for 30 minutes before being allowed to cool to 
room temperature and anneal on the benchtop.  dsRNA was digested with RNAse and 
DNAse for 30 minutes to remove any contaminating single-stranded nucleic acids.  
dsRNA was checked for size and integrity using agarose gel electrophoresis.     
For dsRNA experiments, S2 cells were grown in 250 mL shake flasks to a 
density of approximately 1×106 cells/mL in SFM.  dsRNA was added directly to 6 
mL of cells at final concentrations of 15 and 30 µg/mL.  After incubating in an orbital 
shaker (27 ºC, 50 rpm) for 1 hour with dsRNA, 12 mL of fresh media containing 
insulin to a final concentration of 2.5 µM was added to the cells.  Aliquots were then 
taken for determining initial cell counts.  Treatments were tested in at least duplicate 
flasks with triplicate measurements.     
Differential display (semi-quantitative RT-PCR) 
 For determining relative transcript levels, S2 cells were lysed and RNA 
extracted using an RNAqueous kit (Ambion) as per the manufacturer’s instructions.  
RNA concentration was determined by measuring the absorbance of a diluted sample 
at the 260 nanometer wavelength in a UV spectrophotometer (Beckman).  Total RNA 




DNA template.  The DNA template was subject to PCR with sequence-specific 
primers.  PCR products were run on a 1% agarose gel to compare band intensities. 
Western blot analysis 
   In order to insure that cells transfected with dsTSC1 exhibited the anticiptated 
phenotype, total protein was extracted as described previously (Clemens et al. 2000) 
from cultures exposed to 30 µg/mL dsTSC1 or an equal volume of nuclease-free 
water (as a control) for 96 hours.  Protein extracts were measured for total protein 
concentration using a Pierce BSA protein assay kit as per the manufacturer's 
instructions.  Fifteen micrograms of total protein was loaded onto an SDS-Page gel.  
Following electrophoresis, the gels were blotted onto nitrocellulose and probed with 
monoclonal antibodies against S6K and S6K phosphorylated at Thr389 (Cell 
Signaling Technology, MA).  Blots were subsequently washed and probed with 
alkaline phosphatase-conjugated secondary antibody (Sigma, MO) before being 
probed with a solution of 18.75 mg/ml nitroblue tetrazolium chloride and 9.4 mg/ml 
5-bromo-4-chloro-3-indolyl-phosphate, toluidine salt in 67% (DMSO) (v/v) 
(NBT/BCIP) (Roche, IN).  Following color development blots were scanned and 
analyzed with Scion Image software to determine the relative difference in S6K 
phosphorylation between treatments.   
Results and Discussion 
Insulin effects on growth 
 In order to determine the effect various concentrations of insulin have on S2 




15 µM insulin-containing medium without serum.  Insulin addition to 5, 7.5, and 15 
µM resulted in cessation of growth after 1 to 2 days.  Trypan blue exclusion staining 
of these cells resulted in cell disruption (Fig. 4). 
 
Figure 4. 
Insulin concentration can affect S2 cell membrane integrity.  S2 cells were incubated 
for up to 48 hours with various concentrations of insulin and stained with trypan blue.  
Blue stain smudges indicate cell membrane disruption.  Concentrations of insulin 






In panels A, B and C, very little cell disruption can be seen.  In panel D, some 
disruption is present, and this effect increases in panels E and F.  Panel F cells (15 
µM insulin) were almost all completely lysed following trypan blue staining.  Of the 
remaining lower concentrations, 2.5 µM appears to have the most positive effect on 
growth (Fig. 5), while having no readily visible negative effect on physiology (Fig. 4, 
panel C).  One possible explanation for the apparent weakening of the cell membrane 
at higher concentrations of S2 cells could be that insulin stimulation encourages 
growth at a rate that supercedes that of lipid synthesis.  It has been shown that 
interrupting insulin signaling in adult Drosophila results in mutants that have almost 
twice as much lipid as controls (Bohni et al. 1999).  However in KC cells, the data 
regarding insulin effects on lipid synthesis are inconclusive (Ceddia et al. 2003).  It 
remains to be seen whether or not lipid levels are directly controlled by insulin 
signaling, but the images presented are consistent with this possibility.    
Cells grown in serum-free medium supplemented with 2.5 µM insulin 
exhibited a significantly increased growth rate and an apparent increase in the 
maximum cell number (Fig. 5).  The specific growth rate of cells supplemented with 
2.5 µM insulin was 46 % higher than that of cells without insulin.  Correspondingly, 
cells with 2.5 µM insulin grew 21 % and 17 % higher than cells with 0.25 µM insulin 
and 0.05 µM insulin, respectively (Fig 5, inset).  Overall, the growth rate of the cells 





Insulin increases the cell growth rate in S2 cell culture.  Insulin supplementation level 
is indicated in the legend.  Cells were grown in shake flasks (28 ºC, 50 rpm) for the 
time indicated.  Cell counts were performed in duplicate for duplicate flasks using 
trypan blue exclusion staining. Inset: Insulin supplementation increases the specific 
growth rate, µ during the first 48 hours of growth.  Double stars (**) indicate 
significant difference ( p ≤ 0.001) for the 2.5 µM insulin-supplemented cells (×) 
versus the non-insulin supplemented control ( ).  A star (*) indicates significant 
difference (p ≤ 0.01) for the 0.05 µM ( ) versus the non-insulin-supplemented 
control.  For 0.25 µM insulin-supplemented cells ( ), µ was also significantly 
greater than it was for non-supplemented cells (p≤ 0.1). 
 
 





Tsc1 expression and inhibition 
 TSC1 transcription was investigated under various conditions.  Cells were 
grown in serum-free media with and without insulin supplementation.  Differential 
display after 24 hours indicated that TSC1 transcription is only slightly influenced by 
insulin supplementation (2.5 µM) (Fig. 6).  After 48 hours, when the culture is still 
growing exponentially, the transcription level of TSC1 is relatively unchanged from 
24 hours.  By 72 hours the 35 mm plate cultures are, by in large, growing more 
slowly and the transcription of TSC1 is reduced relative to the 24-hour transcript.  
These data may indicate the important role TSC1 plays in regulating cell growth in 
the presence of nutrient stimulation, which has a greater effect on TSC1 transcription 
than insulin addition (Fig. 6).  TSC1’s role as a controller of the insulin signaling 
pathway and its implication in cancerous growth when mutated, point to a potential 
role for TSC1 in regulating metabolism in response to environmental stimulus: a role 
that was elucidated for TSC1and its co-suppressor, TSC2 by Gao and coworkers (Gao 
et al., 2002).  In that study, loss of TCS1/TSC2 mediated the effects of amino acid 
starvation, which normally would inactivate downstream components of the insulin 
signaling pathway, slowing growth. Our results, where the depletion of nutrients and 
concurrent growth retardation over time tracks with lower TSC1 transcription, further 
implicates TSC1 as a metabolic “throttle” that is itself regulated by cell growth or the 





TSC1 mRNA expression in S2 cell culture.  Mid-exponential growth S2 cells were 
grown in 35 mm culture plates either in an incubator (27ºC) in SFM with (+) or 
without (−) insulin supplementation (2.5 µM).  Total RNA was extracted after 24, 48, 
and 72 hours and differential display of TSC1 mRNA was performed as described in 







 To determine the direct effect that inhibiting TSC1 has on cell growth, we 
transiently blocked TSC1 transcription using dsRNA.  Our idea was that we could 
stimulate growth beyond what had been seen in the previous insulin experiments 
without causing cell lysis.  That is, if TSC1 was acting as a down-regulator of cell 
growth in the presence of insulin, it is possible that by targeting the specific 
controller, one would avoid the wider-reaching effects from increased insulin (such as 
altered lipid synthesis and propensity to lyse), effectively “tuning” the metabolic 
response.  S2 cells were transfected with either 15 µg/mL dsTSC1, 30 µg/mL 
dsTSC1, or no dsRNA and were counted at regular intervals to measure cell growth 
(Fig. 7).  These cells were transfected at time zero, then stimulated with an insulin 
pulse of 2.5 µM at 60 hours post-transfection.  The addition of this amount of insulin 
was determined from our previous experiments to stimulate growth but without lysis, 
and the timing is comparable with the timing shown to inhibit apoptosis in 
recombinant cell culture (Yun et al. 2003).  In both cases of dsTSC1 addition, a 
significant acceleration of the growth rate was observed.  Notably, this growth rate 






Double-stranded RNA against TSC1 increases growth in S2 cell culture.  Cells were 
incubated with either 15 µg/mL or 30 µg/mL dsRNA against TSC1 for 1 hour before 
adding insulin to 2.5 µM in fresh serum-free media.  Arrow indicates an addition of 
2.8 µg/mL insulin 60 hours after the initial incubation with dsRNA.  Inset: dsRNA 
against TSC1 increases the specific growth rate, µ during the time from 48 hours to 
84 hours after intial incubation with dsRNA.  This was thought to be the time that 
TSC1 gene expression was reduced based on differential display data.  Star (*) 
indicates significant difference at the p ≤ 0.02 level for the 30 µg/mL ( ) and the 15 







RNA extracts were analyzed with differential display to determine the 
efficacy and duration of the transcriptional silencing.  The level of TSC1 mRNA 
decreased significantly for up to at least 72 hours, and had apparently recovered by 96 
hours (Fig. 8).  This transient effect has been reported in the literature and was 
expected due to the proposed mechanism of dsRNA post transcriptional gene 
silencing in which the antisense strand of dsRNA combines stoichiometrically with 
complimentary native mRNA to form a complex for degradation (Bernstein et al. 
2001).  Thus, after considering the potential time required for its degradation and 
subsequent synthesis, it was estimated that the time over which the cells were least 
likely to have active hamartin was between 48 and 84 hours post-transfection.  Even 
after 96 hours, however, western blot analysis of downstream TOR-regulated S6K 
indicated that S6K phosphorylation was still considerably higher in the dsTSC1 cells 
(30 µg/mL) than in the non-dsRNA control (Fig. 9).  This represents independent 
confirmation of dsRNA activity towards TSC1, and further suggests that timing the 
insulin pulse at 60 hours appeared appropriate for stimulating S6K phosphorylation.  
The specific growth rate (µ) was calculated over this time and was found increased by 
11 % for the 15 µg/mL dsTSC1-treated cells and by 20 % for the 30µg/mL dsTSC1-






Double-stranded RNA against TSC1 (dsTSC1) specifically inhibits TSC1 
transcription for at least 72 hours in shake flask cultures of S2 cells.  Cells were 
transfected with 15 µg/mL dsTSC1, 30 µg/mL dsTSC1, or No dsRNA.  Differential 
display of mRNA from cell extracts measured relative expression of TSC1 and the 
gene encoding glyceraldehyde-3-phosphate dehydrogenase (gapdh) at 3 timepoints: 









Western blot analysis of S6K and phosphorylated S6K levels in cells treated with 
dsTSC1.  Cells were transfected with dsTSC1 (A.) or an equal volume of nuclease-
free water (B.).  Equal amounts (15 µg) of protein extract were loaded onto SDS-page 
gels and subsequently blotted onto nitrocellulose and probed with monoclonal 
antibodies to either phosphorylated S6K (phospho-S6K) or S6K (S6K).  Western 
blots were scanned and analyzed for relative band intensity.  Each bar in the chart 
indicates the ratio of phospho-S6K band intensity divided by S6K band intensity for 








 We have shown here that RNAi has tremendous potential for the metabolic 
engineering of Drosophila S2 cells.  TSC1 transcription was higher in exponentially 
growing cells passaged in fresh media. That TSC1 expression was higher under these 
conditions suggests that the cells temper the benefits of nutrient addition by using 
TSC1 as a metabolic throttle. We found that targeted inhibition of the TSC1 increased 
the specific growth rate of S2 cells beyond that of insulin addition, without apparent 
side effects.  Our results are consistent with what is already known about insulin 
signaling and importantly, provide a framework from which to explore more 
completely the area of cellular signaling in the context of metabolic pathway 
manipulation.        
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Chapter 4: Increasing protein yield through metabolic 
engineering of signal transduction and cell cycling in 
Drosophila S2 cells 
 
Abstract 
 We have demonstrated the interruption of cellular controllers to increase 
product yield in Drosophila Schneider 2 (S2) cell culture.  Components of insulin 
signaling (TSC1 and dPTEN) and cell cycling (CycE and Archipelago) were silenced 
using RNA interference (RNAi).  Double-stranded RNA (dsRNA) against TSC1 and 
CycE showed the most significant level of silencing, while dsRNA against ago, 
TSC1, and CycE resulted in the highest increases in product yield: 84%, 50%, and up 
to 400% respectively.  Complete silencing of CycE resulted in no significant change 
in expression after 24 hours, and a decrease in expression after 72 hours.  This is 
likely due to the fatal effects of CycE inhibition.  By lowering the level of silencing 
for CycE we were able to increase protein synthesis substantially (400%).   
 
Keywords: Drosophila, S2, Sl-2, cell culture, insulin, dPTEN, harmartin, TSC1, 
tubular sclerosis, RNAi, CycE, Cyclin E, Archipelago, Ago, cell cycle, GFP  





Introduction   
Metabolic engineering has, in recent years, turned a corner with respect to the 
level of sophistication by which the cell's metabolism is viewed and what constitutes 
an appropriate level of manipulation with cellular processes.  Previously, researchers 
focused on central metabolic pathways for the re-distribution of carbon toward 
product or away from harmful secondary metabolites.  This represented a one 
dimensional view of biochemical reaction pathways.  The advent of more cellularly 
benign and user-friendly techniques, such as RNAi coupled with the increase in 
biophysical and biochemical information being generated over the past decade, has 
shifted focus from central metabolism to cellular signal transduction and other 
cellular functions including subcellular assemblies.  Recent examples include 
interrupting viral cellular receptor proteins to combat AIDS (Anderson et al. 2003) 
and interrupting tumor development in cancer (Sumimoto et al. 2004a; Sumimoto et 
al. 2004b).  These studies made use of RNAi to inhibit pathogenicity through the 
signaling cascades that initiate or regulate an infection or tumorogenesis.   
 For metabolic engineers, this fits into the greater trend of thinking about 
cellular function more in terms of discreet events, rather than in terms of steady-state 
kinetics.  After pioneering work that took advantage of varying growth states in the 
cell cycle to enhance recombinant protein synthesis (Abu-Absi and Srienc 2000; 
Fussenegger and Bailey 1998; Fussenegger et al. 1998), control of protein synthesis 
regulation has become an important tool for enhancing recombinant protein yield, and 
RNAi in particular has emerged as a simple, yet powerful method for controlling gene 




 The transient nature, seemingly low metabolic burden, relative ease of use, 
and high efficacy of RNAi make it attractive from the standpoint metabolic 
engineering.  RNAi can be synthesized in vivo or synthesized in vitro and transfected 
into cells.  Both methods have proven effective for gene silencing.  Work in our 
laboratory used in vitro-synthesized double-stranded RNA to silence various genes in 
Tricopusa ni larvae (Kramer and Bentley 2003) and Drosophila melanogaster S2 
cells (this work) for increased green fluorescent protein (GFP) expression.  Other 
studies have investigated the use of in vivo RNAi synthesis for increasing transient 
protein expressing in HEK293 cells (Hacker et al. 2004).   
Here we investigated the use of in vitro-transcribed RNAi for metabolic 
engineering of specific cellular controllers in S2 cells.  Drosophila, like vertebrates, 
are capable of developing tubular sclerosis complex (TSC): a disease marked by 
benign tumors called harmatomas.  The disease results from mutation of either TSC1 
or TSC2, the genes encoding for hamartin and tubulin, respectfully.  These proteins 
form a complex that inhibits downstream phosphorylation of S6K, which has 
downstream transcriptional and translational targets.  Once activated S6K can 
increase the transcription of the 4E-BP transcriptional activator, leading to increased 
protein synthesis and cell growth.  The effect of TSC1 or TSC2 mutation in whole 
flies and mammalian cells is the same, specifically that cells grow two to four times 
normal size and over proliferate (Aicher et al. 2001; Ito and Rubin 1999; Miloloza et 
al. 2000; Potter and Xu 2001; Soucek et al. 1997; Tapon et al. 2001b).  TSC is an 
important element in the insulin signaling pathway, and acts there to inhibit cellular 




TSC acts as a sensor of nutrient availability and down-regulates growth in the 
absence of excess amino acids.  We recently demonstrated that S2 cells in culture also 
increase their growth rate when stimulated by insulin, an effect that is amplified by 
the mutation of TSC1 (in review).     
Another regulator of insulin signaling in Drosophila is dPTEN, which encodes 
a phosphatase that responds to insulin stimulation by dephosphorylating PIP3, and 
thereby inhibiting downstream growth stimulation.  Cells mutated for dPTEN exhibit 
increased cell size and proliferation (Gao et al. 2000).  Some models of insulin 
signaling put dPTEN directly upstream from TSC1, making the regulation redundant.  
However, a recent review hypothesizes that dPTEN and TSC1 may be part of 
independent pathways that respond to nutrient levels separately, but these genes 
respond to to insulin through the same pathway.  This hypothesis is only supported 
for whole flies, which likely have greater crosstalk capability than do cells in culture 
(Pan et al. 2004). 
It is widely accepted that the eukaryotic cell cycle can be divided into regions 
of enhanced protein synthesis, DNA replication, and finally, division.  The G0/G1 
phase of the cell cycle is thought to be the point at which cells produce the most 
protein and, as a consequence, the most translational machinery.  It is therefore been 
of interest to metabolic engineers to control cycling cells to remain in G0/G1 to 
increase synthesis of a recombinant protein (Abu-Absi and Srienc 2000).  Successful 
attempts have been reported (Fussenegger et al. 1998; Lee et al. 1996; Mazur et al. 
1998), and models of cell cycle regulation for enhancement of particular 




from G1 of the cell cycle is mediated by Cyclin E.  Regulation of Cyclin E is 
complicated and involves transcriptional, translational, and degradative elements (Qu 
et al. 2003a; Qu et al. 2003b).  Degradation of Cyclin E is mediated by Archipelago 
(encoded by ago) and carried out by the ribosomal 26 S protease (Moberg et al. 
2001).  Mutations in archipelago result in elevated growth of human cell lines and 
Drosophila whole flies (Moberg et al. 2001).  For this reason, Archipelago was 
selected as a potential target for silencing by RNAi.  The silencing of ago and CycE 
have beneficial effects on recombinant protein synthesis, presumably through 
different mechanisms.  By inhibiting Cyclin E synthesis, the cells are forced to 
remain in G1, and not expend energy on cell division.  By inhibiting ago expression, 
the culture is forced into a higher growth state, possibly increasing pools of protein 
synthesis machinery and thereby producing more recombinant product.  TSC1 and 
dPTEN were equally of interest as silencing targets, since they also worked to slow 
growth and proliferation.  This work investigated the targeted inhibition of these 
growth regulators in an attempt to increase the cell's capacity to synthesize proteins of 
interest.        
Materials and Methods 
Cell culture, stable cell line, and induction 
For all experiments, Drosophila melanogaster Schneider 2 (S2) cells were 
grown in Drosophila serum-free media (SFM) (Invitrogen, Carlsbad, CA) in 
untreated 35 mm petri plates at 27 ºC and 50 rpm in an orbital shaker.  Cells were 
maintained at approximately 5×105 cells/mL to 6×106 cells/mL.  Cell density was 




GFP was PCR amplified from pGFP (Invitrogen) and ligated into the 
pMtV5hisB Drosophila expression vector (Invitrogen, Carlsbad, CA) downstream of 
the metallothioneine (Mt) promoter to make pMt-GFP.  S2 cells were co-transfected 
with pMt-GFP and pCoHygro (Invitrogen) encoding hygromycin resistance, at a ratio 
of 44:1 in twelve-well plates.  Cellfectin (Invitrogen) was used to transfect the cells as 
per the manufacturers instructions.  Cells were incubated for 12 hours in SFM plus 
10% FBS and then washed once in SFM without FBS before being covered with SFM 
plus 10% FBS and 250 µg/mL hygromycin.  After three to five weeks of hygromycin 
selective pressure, stable cells expressing GFP were selected and transferred to 75-
mL T-flasks.  These cells (S2-GFP) were thereafter maintained in SFM plus 250 
µg/mL hygromycin.   
For protein expression experiments, CuSO4 was added to the media to a final 
concentration of 10 µM to induce transcription of GFP.  In all experiments GFP 
expression was measured within 24 hours of induction.  For cells transfected with 
dsTSC1, dsDPTEN, dsAgo, dsCycE, or nuclease-free water, incubation was carried 
out for 48 hours before induction with CuSO4.  For other cells transfected with 
dsCycE or nuclease-free water, incubation was carried out for two hours before 
induction with CuSO4. 
dsRNA synthesis and transfection 
dsRNA was synthesized following the method of Clemens et al. (2000).  
Briefly, S2 cells were stimulated with bovine insulin (2.5 µM) to synthesize 
components of the insulin signaling pathway.  After 0.5 to 2 hours, RNA was 




manufacturer’s protocol.  First strand copy DNA (cDNA) templates of TSC1, 
DPTEN, CycE, and Ago were synthesized from the mRNA using OligodT primers 
and the Retroscript® kit (Ambion) as per the manufacturer’s instructions.  700 
basepair regions of first strand cDNA templates were PCR amplified using the PCR 
MasterMix™ kit (Taq DNA polymerase) from Promega (Madison, WI) and TSC1 
(5’-ATG ACG CTG GAG AAC GAG GAG GCC AAG CGC-3'; 3’-CCA TCT CCT 
TCC ATC GCG TAT TGT TTA CCT-5'), dPTEN (5'-TAA TGT CCA ACG TGA 
TAC GCA ATG-3'; 3'-GCA AGG TTT TCA GTC TAT CTG-5'), CycE (5’-ATG 
GGT TTA AAT GCC AAG AGT-3'; 3'-CAC CAC CAC TGG CGT CTG CTT-5'), 
and ago (5'-ATG AGG AAC CCG AGC CGG AGG-3'; 3'-AGG TTG AGC TGG 
AGT TGG AAG-5')-specific primers.  T7 sequences were added to the templates 
(making them T7 templates) using T7 primers, which were comprised of the first 15 
to18 nt of the template primers (described above) downstream from a T7 promoter 
sequence  (5’-TAA TAC GAC TCA CTA TAG GG - 3').  To make the dsRNA, T7 
templates were used with the Megascript™ kit (Ambion) as per the manufacturer’s 
instructions.  The single-stranded RNA (ssRNA) synthesized was extracted using 
phenol/chloroform and resuspended in nuclease-free water to a concentration of 
approximately 3.3 µg/µL.  dsRNA was checked for size and integrity using agarose 
gel electrophoresis, after digestion with RNAase and DNAse for 30 minutes to 
remove any contaminating single-stranded nucleic acids.     
For dsRNA experiments, S2 cells were plated in 35-mm untreated petri plates 
to a density of approximately 1.5 ×106 cells/mL in SFM.  dsRNA or an equal volume 




30 µg/mL.  After incubating in an orbital shaker (27 ºC, 50 rpm) for 1 hour with 
dsRNA, 2 mL of fresh media containing insulin to a final concentration of 2.5 µM 
was added to the cells.  Treatments were tested in at least triplicate plates with 
triplicate measurements.     
Differential display (semi-quantitative RT-PCR) 
 For determining relative transcript levels, S2 cells were lysed and RNA 
extracted using an RNAqueous kit (Ambion) as per the manufacturer’s instructions.  
RNA concentration was determined by measuring the absorbance of a diluted sample 
at the 260 nanometer wavelength in a UV spectrophotometer (Beckman).  Total RNA 
was subject to reverse transcription using oligodT primers to obtain the first-strand 
cDNA template.  The cDNA template was subject to PCR with sequence-specific 
primers: TSC1 (5’-ATG ACG CTG GAG AAC GAG GAG GCC AAG CGC-3'; 3’-
CCA TCT CCT TCC ATC GCG TAT TGT TTA CCT-5'), dPTEN (5'-TAA TGT 
CCA ACG TGA TAC GCA ATG-3'; 3'-GCA AGG TTT TCA GTC TAT CTG-5'), 
CycE (5’-ATG GGT TTA AAT GCC AAG AGT-3'; 3'-CAC CAC CAC TGG CGT 
CTG CTT-5'), and ago (5'-ATG AGG AAC CCG AGC CGG AGG-3'; 3'-AGG TTG 
AGC TGG AGT TGG AAG-5').  PCR products were run on a 1% agarose gel stained 
with ethidium bromide to compare band intensities under fluorescent light.  Primers 
against a 900 bp section of glyceraldehyde dehydrogenase (GAPDH) (5'-CCA GAA 
GAT CAC CGT GTT-3'; 3'-CCC TTG CGG ATT ATG CAA-5') were used to PCR 
amplify a loading control from the reverse transcript.  For attenuated silencing of 
CycE, photographs of agarose gels under UV light were analyzed for band intensity 






 Following 24 hours of induction, the S2 cells were centrifuged (400 × g, 4 
min., 4ºC) and washed in ice-cold PBS before fixing in ice-cold PBS with 4% 
formaldehyde.  The fixed samples were immediately subject to flow cytometry 
(FACSCalibur, BD Bioscience, NJ).  To determine GFP expression, 20,000 cells 
were exited at 488 nm and emission was measured at 530 nm.  Samples were gated 
using forward- and side-scatter dot plots to remove cell fragments and aggregates 
from the analysis.  Histograms were generated by plotting counts against fluorescence 
intensity.   
 To determine cell cycling, S2 cells transfected with dsCycE, dsAgo, or 
nuclease-free water were centrifuged (400 × g, 4 min., 4ºC) and washed in ice-cold 
PBS before fixing (70% ethanol, 30% PBS, -20ºC), and stored overnight at -20ºC.  
Fixed cells were incubated with 20 µg/mL RNAseA (30 min, 37ºC) and, 
subsequently, 83 µg/mL propidium iodide (PI) (5 minutes, room temperature) before 
being analyzed on the flow cytometer (FACScalibur, BD Bioscience, NJ).  To 
determine PI incorporation into genomic DNA, 20,000 cells were exited at 488 nm 
and emission was measured at 618 nm.  Because of the rapid turnover rate of Cyclin 
E, dsCycE cells and a no-dsRNA control were fixed 26 hours after transfection with 
dsRNA.  dsCycE cells and a no-dsRNA control were induced to produce GFP 2 hours 
after transfection with dsRNA, allowing 24 hours to synthesize GFP prior to analysis.  
The dsAgo cells were grown for 72 hours post transfection to allow for Ago turnover 





Western blot analysis 
   In order to insure that cells transfected with dsTSC1 and dsDPTEN exhibited 
the anticipated phenotype, total protein was extracted as described previously 
(Clemens et al. 2000) from cultures transfected with dsTSC1, dsDPTEN, or an equal 
volume of nuclease-free water (as a control) for 72 hours.  Protein extracts were 
measured for total protein concentration using a Pierce BSA protein assay kit as per 
the manufacturer's instructions.  Fifteen micrograms of total protein was loaded onto 
an SDS-Page gel.  Following electrophoresis, the gels were blotted onto nitrocellulose 
and probed with monoclonal antibodies against S6K and S6K phosphorylated at 
Thr389 (Cell Signaling Technology, MA).  Blots were subsequently washed and 
probed with alkaline phosphatase-conjugated secondary antibody (Sigma, MO) 
before being probed with a solution of 18.75 mg/ml nitroblue tetrazolium chloride 
and 9.4 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate, toluidine salt in 67% (DMSO) 
(v/v) (NBT/BCIP) (Roche, IN).  Following color development blots were scanned 
and analyzed with Image J software (NIH) to determine the relative difference in S6K 
phosphorylation between treatments.  
    
Results and Discussion 
Gene silencing 
 After transfection with 30 µg/mL dsRNA against specific targets: dPTEN 




extracted from the cultures and digested with DNAase prior to differential display 
analysis as described in Materials and Methods.  Each column in Fig. 10 represents 
either a dsRNA treatment or a control.  The primers used in the differential display 
are listed along the left of each agarose gel.  Differential display of dsDPTEN-, 
dsTSC1-,  and dsAgo-transfected cells was performed 48 hours post-transfection (Fig. 
10A, B and  F, respectively), while for dsCyclinE-transfected cells RT-PCR was 
conducted 26 hours and 72 hours post-transfection.  With each experiment, a control 
transfected with nuclease-free water instead of dsRNA was used to compare relative 
gene transcription levels.  For dsDPTEN- and dsTSC1-transfected cultures, the 
control can be seen in Fig. 10C.  For 26-hour dsCycE-transfected cells, the control is 
in Fig. 10E.  For dsAgo-transfections, the non-transfected control is in Fig. 10G.  
PCR products of GAPDH are provided as a loading control for each sample (Fig. 
10A-G).  The 72 hour dsCycE-transfected cells, which received less than 30 µg/mL 
dsCycE, are discussed in detail in another section (Tuning gene silencing) and are not 
shown in Fig. 10.  
Gel band intensities indicated that TSC1 and CycE were almost completely 
silenced by 30 µg/mL dsRNA (Fig. 10B and Fig. 10D, respectively).  However, 
dPTEN and ago were not as completely silenced (Fig. 10A and F, respectively) 
relative to their controls as TSC1 and CycE (Fig. 10B and D, respectively) but still 
exhibited some reduction in their transcription.  Interestingly, a decrease in the 
transcript levels of ago resulted in an increase in CycE transcript levels (Fig. 10F and 
D, respectively).  This was reasonable, since Cyclin E transcription can be controlled 




2000).  In developing flies (from which S2 cells were derived) Cyclin E and other 
proteins phosphorylate retinoblastoma (RB), causing RB to disassociate from dE2F1 
(a transcriptional activator).  dE2F1 is thought to stimulate the transcription of CycE 
(Brumby et al. 2002; Lee and Orr-Weaver 2003).  Hence, a reduction in Cyclin E 
degradation stemming from the silencing of ago would lead to an increase in CycE 






Silencing of target genes.  Reverse transcription and subsequent PCR (differential 
display) of target genes was carried out from total RNA after DNAase digestion using 
oligodT primers.  The samples were gathered 48 hours post-transfection with dsRNA 
unless otherwise noted.  The gene specific primers used for the PCR are listed at the 
far left of each figure.  (A)  Cells transfected with dsRNA against dPTEN 
(dsDPTEN), (B) Cells transfected with dsRNA against TSC1 (dsTSC1), (C) Cells 
transfected with water as a control, (D) Cells transfected with dsRNA against cycE 
(dsCycE) 24 hours post-transfection, (E) Cells transfected with water as a control 24 
hours post-transfection, (F) Cells transfected with dsRNA against ago (dsAgo), (G) 
Cells transfected with water as a control.  Primers against GAPDH were used as a 











Physiological effects of silencing 
 To determine the effect of silencing cell cycling–related genes on cell cycling, 
samples were subject to propidium iodide (PI) staining.  Cells were harvested from 
each treatment (dsAgo and dsCycE) and control and fixed in ice-cold ethanol 
overnight before incubation with ribonuclease A and subsequent staining with PI.  PI-
stained cells were analyzed with a flow cytometer to determine DNA content.  After 
gating the samples to remove aggregates and lysed cells, histograms were generated 
from 20,000-cell samples for their emission intensity at 618 nm.  The histograms 
were analyzed using Cellquest software for the approximate percent distribution of 
cells in three phases of the cell cycle (G1, S, or G2/M).  Figure 11 gives typical 
results for PI staining histograms.   
DNA staining indicated that dsCycE-transfected cells at the highest 
concentration (30 µg/mL) (Fig. 11B) were almost 2-fold more in G1 of the cell cycle 
than the non-transfected control (Fig. 11A) after 26 hours of transfection.  After 72 
hours of the most concentrated transfection with dsCycE (30 µg/mL) cells were 
mostly dead so that no RNA sample was gathered (data not shown).  The histogram in 
Fig. 2B indicates that the silencing of Cyclin E had its desired effect after 24 hours.  
The speed with which this occurred may stem from the need to reset Cyclin E levels 
after S phase, in order that cells can spend sufficient time in G1 following mitosis for 
biosynthesis of cellular components and replication machinery.  Cell death after 72 
hours of treatment with 30 µg/mL dsCycE points to a vital function for Cyclin E, 




genome-wide microarray analysis has demonstrated that silencing Cyclin E can be 
(Boutros et al. 2004).  The interaction of Cyclin E with the transcriptional activator 
dE2F1 may result in activation of essential targets that are needed to maintain cell 
viability, even when the cell is not dividing.      
dsAgo-transfected cells were 74% in G2/M after 72 hours (Fig. 11C).  These 
data lend support to the hypothesis that accumulation of Cyclin E results in more 
rapidly dividing cells.  In fact, elevated levels of Cyclin E have been linked to 
tumorous growth in adult flies (Jia et al. 2003).  Transfection of cells with dsAgo may 
prove a useful tool in future studies to hold cells in G2 of the cell cycle. 
The target of insulin signaling gene silencing (dPTEN and TSC1) was the 
transcriptional and translational activator dS6K, since phosphorylation of dS6K 
results in increased cell growth and proliferation.  Normal function of dPTEN and 
TSC1 mediate dephosphorylation of dS6K.  Protein extracts were prepared as 
described in Materials and Methods for cultures treated with dsDPTEN, dsTSC1, or 
nuclease-free water.  Western blot analysis with antibodies specific for 
phosphorylated S6K or S6K demonstrated an increase in S6K phosphorylation for the 
dsTSC1-transfected cells (Fig.12B), and almost no change in phosphorylation for 
dsDPTEN-transfected cells (Fig. 12A) when compared to the nuclease-free water 
control (Fig. 12C).  These data corroborated that silencing of insulin-signaling 
pathway components leads to increased phosphorylation of dS6K.  That dsDPTEN-
transfected cultures did not exhibit as much S6K phosphorylation as dsTSC1-




between the two conditions (Fig. 10A and B, respectively).  The difference between 






Propidium iodide (PI) staining of cells transfected with dsRNA.  Cells transfected 
with dsRNA against (A) water as a control, (B) CycE (dsCycE), and (C) ago (dsAgo) 
were fixed in ethanol, stained with PI and analyzed on a FACSCalibur flow cytometer 
to determine DNA content.  After gating to remove cell debris and aggregates, 
histograms were generated for counts (at least 20,000 cells) versus emission intensity 
(618 nm).  Cell cycle estimates (G1, S, or G2/M: inset for each histogram) were made 
using Cellquest software.  Cell cycle results are representative of at least triplicate 







Western blot of S6K phosphorylation.  S2 cells were transfected with dsRNA against 
TSC1 (dsTSC1), dPTEN (dsDPTEN) and water as a control (Control).  After 72 
hours, the cells were lysed and their protein extracted.  25 µg total protein was run on 
a denaturing SDS-page gel, blotted onto a nitrocellulose membrane, and probed with 
antibodies to either S6K (S6K) or S6K phosphorylated on Thr389 (phospho-S6K).  








Recombinant protein expression 
 Stable S2 cell lines were constructed expressing recombinant GFP (S2-GFP).  
S2-GFP cultures were transfected with up to 30 µg/mL dsRNA against specific genes 
(dPTEN, TSC1, Cyclin E) and allowed 48 hours for recovery and protein turnover 
before being induced to express recombinant GFP for 24 hours.  After extraction and 
fixing in 4% formaldehyde, 20,000 cells per treatment were analyzed by flow 
cytometry for GFP fluorescence (530 nm emission).  Cytometry samples were gated 
to remove fragmented and aggregated cells.  Histograms relating counts of cells 
versus emission intensity were generated, and further gated to account for an M1 
population of 20% of the total that exhibited the highest fluorescence intensity.  This 
percentage was calculated by examining samples from the total population using a 
hemocytometer under a fluorescent microscope.   
The greatest increase in relative GFP expression for cells transfected with 30 
µg/mL dsRNA was exhibited by the dsAgo-transfected cells, which were 83% more 
fluorescent than the controls (Fig. 13).  G1 of the cell cycle is the state at which most 
protein synthesis occurs, and we confirmed that cells silenced for ago spend less time 
in G1 than do control cells (Fig. 11A and C).  Indeed, much of the literature regarding 
the cell cycle and heterologous protein expression has demonstrated that holding cells 
in G1 greatly increases specific product synthesis.  However, in order for tissue 
mutant for ago to overproliferate, as has been described (Moberg et al. 2001), there 
must be increased protein synthesis to meet the biosynthetic demands of the rapidly 
growing cell.  While this demand is not met through the mechanism of holding cells 




previously, Cyclin E and dE2F1 can form a complex that not only facilitates the exit 
of the cell from G1 into S, but that also facilitates the transcription of downstream 
targets (Lee and Orr-Weaver 2003).  By allowing the accumulation of Cyclin E, 
silencing ago may have stimulated cell growth through a Cyclin E-dependent 






Protein expression in transfected cells.  S2 cells stably expressing GFP were subject 
to transfection by dsRNA for 72 hours (unless otherwise indicated), fixed in 4% 
formaldehyde and counted on a flow cytometer to determine GFP fluorescence.  Each 
treatment was compared to a control of stably expressing cells that were not subject to 
dsRNA treatment.  The error bars represent the standard deviation of at least three 
independent experiments, all normalized by dividing by the fluorescence of the 
control.  Results of the student's T-Test comparing each treatment to the non-
transfected control are indicated by stars as follows:  ** indicates p < 0.001, * 











































The method of almost completely inhibiting CycE transcription did not 
significantly change GFP expression after 24 hours, and resulted in a significant 
decrease in GFP fluorescence after 72 hours (Fig 13), at which point more than 80% 
of the culture stained dead under trypan blue exclusion staining (data not shown).  It 
was unclear why the nearly complete silencing of CycE would prove ineffective at 
increasing GFP synthesis, and would moreover prove fatal.  A recent genome-wide 
RNAi study confirmed that nearly complete silencing of CycE was fatal to 
Drosophila cell culture (Boutros et al. 2004), but the mechanism for cell death was 
not investigated.  Considering that there must be at least one vital function for Cyclin 
E, attenuated silencing of CycE was investigated to hold cells in G1 while allowing 
for some Cyclin E function. 
Silencing insulin signaling down-regulators dPTEN and TSC1 increased GFP 
fluorescence by 20% and 50%, respectively.  The lower yield resulting from 
transfecting with dsDPTEN (Fig. 13) was in accordance with the level of silencing 
achieved (Fig. 10A).  The 50% increase in yield for dsTSC1-tranfected cultures was 
significantly higher than the control (p≤0.001); however, the level of increase in GFP 
expression did not reflect the more than 3-fold increase in dS6K phosphorylation 
(Fig. 12B and C) for dsTSC1-transfected cultures.  There are no indications from the 
literature that the level of dS6K phosphorylation can serve as a predictor of protein 
synthesis, and it is unlikely that all of the downstream targets of dS6K are beneficial 
to recombinant product yield.  Yet, this result demonstrates the potential of 





Tuning CycE transcription 
 To examine the effect of tunable CycE silencing, various concentrations of 
dsCycE were incubated with S2-GFP cells for 48 hours prior to induction of GFP 
expression for 24 hours (72 hours post-transfection).  Cells were fixed in 4% 
formaldehyde and analyzed with flow cytometry.  After gating the samples to remove 
aggregates and lysed cells, histograms were generated from 20,000-cell samples for 
their emission intensity (530 nm).   The silencing of CycE transcript (Fig. 14B) 
tracked with a significant increase in GFP expression relative to the control 
transfected with nuclease-free water (Fig. 14A).  The greatest increase in fluorescence 
was seen for cultures transfected with 9 µg/mL of dsCycE, which expressed 4-fold 
greater GFP than the control (Fig. 14A).  For cultures transfected with 12 µg/mL and 
30 µg/mL dsCycE, emission intensity was 22% and 90% lower, respectively than for 
cultures transfected with 9 µg/mL dsCycE.  Transfecting with 30 µg/mL dsCycE 
proved to be fatal (data not shown).  Differential display data demonstrated that the 
silencing tracks in accordance with the amount of dsCycE added (Fig. 14B), although 
the transcript difference between 3 µg/mL and 6 µg/mL was not pronounced (Fig. 
14B).  Similarly, the level of GFP expression between these two treatments was not 
significantly different (Fig. 14A). 
To examine the effect of attenuated silencing of CycE on cell cycling, cells 
were fixed in ethanol and stained with propidium iodide (PI) and analyzed using flow 
cytometry as described in the Materials and Methods.  Histogram plots were 
generated from 20,000-cell samples after gating to remove fragmented and 




revealed that even for low levels of dsRNA (3 to 6 µg/mL) the cell cycle shifts 
dramatically from predominantly G2- to mostly in G1- or S-phase of the cell cycle 
(Fig. 14C).  At concentrations of dsCycE above 6 µg/mL, the shape of the intensity 
histogram became more mounded as cells were more clumped and perhaps apoptotic.  
These profiles may serve as an indicator as to what point the silencing of CycE begins 
to have a detrimental effect on cell growth and survival.  While the silencing at the 9 
µg/mL level yielded the most GFP fluorescence, it may have been the threshold 
silencing level at which the overall health of the cell was beginning to be 
compromised.   






GFP and CycE mRNA expression in transfected cells.  S2 cells stably expressing GFP 
were subject to transfection by various concentrations of dsRNA against CycE for 72 
hours.  A.  For fluorescence measurements each treatment was compared to a control 
of stably expressing cells that were not subject to dsRNA treatment.  The amount of 
dsRNA (µg/mL) transfected into each treatment is listed below its fluorescence 
(numbers on the X-axis: 0, 3, 6, 9, 12).  Error bars represent the standard deviation of 
at least two independent experiments, all normalized by dividing by the fluorescence 
of the control.  Results of the student's T-Test comparing each treatment to the non-
transfected control are indicated by stars as follows:  ** indicates p < 0.001, * 
indicates p < 0.05. B.  Representative differential display of the level of CycE 
transcript is shown for each treatment below the corresponding relative fluorescence.  
The plot under the gel display indicates the normalized (CycE band intensity/ 
GAPDH band intensity) intensity for each treatment.  The primers used for 
differential display PCR are indicated at the left of each row.  C.  Profiles of PI-
stained cells after 72 hours treatment by dsRNA against CycE.  Amounts of dsRNA 
transfected are inset for each profile (0, 3, 6, 9, or 12 µg/mL).  Cells were fixed in 
70% ice cold ethanol overnight before staining with propidium iodide and reading on 
the flow cytometer.  Images indicate the shift of cycling from most G2 (control) to 
mostly G1 (3, 6, and 9 µg/mL dsRNA), to non-discernable (12 µg/mL dsRNA). 






















This result clearly marks RNAi a powerful tool in metabolic engineering of 
eukaryotic systems.  With tunable silencing such as exhibited here in the case of 
Cyclin E, it will be possible to modulate gene expression without having to synthesize 
additional proteins and imparting the consequent metabolic burden.  As the 
comparison of more fully silenced (30 µg/mL, Fig. 13) to more fully expressed CycE 
(9 µg/mL) illustrates, there are conditions within a culture that require optimized gene 
expression for maximized system performance.  With this relatively simple system of 
dsRNA in vitro enzymatic synthesis, and subsequent insulin or FBS-mediated 
transfection, several expression scenarios are possible and can be rapidly screened in 
a high throughput platform.  Furthermore, for complete silencing the cost of 
developing knockout strains is circumvented, and Drosophila S2 lines provide an 
industrially attractive organism from which to work.   
 We have shown here the expansion of the technique of using RNAi for 
metabolic engineering of eukaryotic cell culture.  In particular, it has been shown that 
silencing genes related to tumorogenic growth in whole animals can have a positive 
effect on recombinant protein expression.  The genes TSC1 and ago are potent down-
regulators of cellular growth in whole animals.  In cell culture they play a similar 
role, but it may be unnecessary.  Cell cultures grow in well maintained environments 
that are intended to encourage maximum growth and protein synthesis.  In such 
conditions, we have shown here that removing cellular controllers may increase 
cellular capacity to produce protein, including recombinant product.  By controlling 




extraneously to have a range of physiological effects from cell death to greatly 
increased protein expression.         
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Chapter 5:  Conclusions 
Insulin effects on physiology and dsRNA uptake 
The work presented in chapter one investigated the use of insulin to stimulate 
dsRNA uptake by S2 cells growing in in vitro.  The results indicated two important 
aspects of dsRNA gene silencing: 1) that insulin could stimulate S2 cells growing in 
serum-free media to take up dsRNA of 700 basepairs, and 2) that the amount of 
dsRNA added to the culture determines the level of transcript expressed after a 
defined period.  These results are important to metabolic engineers studying insulin 
signaling, in that they enable the removal of fetal bovine serum (FBS) from the 
transfection process, and they indicate potential for tuning gene expression in 
recombinant eukaryotic culture. 
 In Chapter 2 the effects of insulin addition to shake flask cultures of 
S2 cells were investigated.  In that study it was shown that the supplementation of 
insulin resulted in an increase in the specific growth rate of the culture.  Additionally, 
the effect of insulin supplementation on cell physiology (membrane integrity) 
following trypan blue exclusion staining was examined.  It was found that cells 
incubated with ≥5 µM insulin would lyse (indicating a loss of membrane integrity) 
when stained with trypan blue, and that the amount of lysis increased with insulin 
concentration.  Further it was found that high concentrations of insulin ≥15 µM 
resulted in cell death (data not shown).  This study marks the first time that the effects 




TSC1 expression and effect on cell growth 
Chapter 3 describes an investigation into how TSC1 transcription can be 
manipulated to change cell growth.  As would perhaps be expected, the level of TSC1 
transcription did not significantly change as a function of insulin stimulation.  TSC1's 
role as signal transduction regulator makes its continued presence necessary and its 
regulation dependent on phosphorylation, rather than transcription.  Only when the 
growth conditions were significantly changed did the transcription of TSC1 markedly 
alter.  As nutrients were depleted and the growth rate of the culture declined, the 
transcription of TSC1 was reduced.   
The TSC1 complex has to be able to respond quickly to changes in nutrient 
availability.  Glucose availability in the adult fly is an example.  There may not be 
sufficient time for cells to react with transcription and translation of a regulating 
protein.  Instead, the transcription level remains constant, and the regulation is 
accomplished through phosphorylation.  In the case of this work, the nearly complete 
removal of hamartin by TSC1 silencing had an effect because there was no possibility 
for growth retardation through this mechansim, as was evidenced by the 
phosphorylation of dS6K and the change in growth rate.  Cells were forced into a 
higher proliferative state by removal of a complex that normally interrupts growth-
promoting signaling cascades.   
Insulin and cell cycling targets effect on recombinant protein synthesis      
 
 In Chapter 4 the effects that silencing specific targets in the insulin and cell 




synthesis seemed to correlate with gene silencing efficacy for targets in the insulin 
signaling pathway (dPTEN and TSC1), but silencing of cell cycling targets had 
varying effects, depending on the target.  For example, silencing ago increased 
protein synthesis by 83%, yet silencing CycE had a gradient effect (from no 
difference in GFP expression to 4-fold higher expression of GFP) depending on the 
level of silencing.  Propidium iodide staining revealed that transfections of more than 
6 µg/mL of dsRNA against CycE resulted in non-distinct cell cycling profiles: 
perhaps indicating the onset of cell death.  It was concluded from these results that 
CycE  had alternate roles in the cell which were not performed under the condition of 
more complete silencing, but that attenuating CycE transcript could hold cells in G1 
of the cell cycle while still allowing for Cyclin E functionality.   
 Overall these studies substantiate the control of signaling pathways as a viable 
approach to engineering cells for increased growth and protein production.  RNAi has 
been shown to be an effective tool for mediating gene silencing for these purposes.  
Future work will endeavor to make stable cell lines expressing dsRNA under control 
of environmentally sensitive promoters to facilitate as-needed gene silencing.  For 
example, cells could be modified to react to low oxygen concentrations in a large 
reactor by expressing RNAi against oxidative phosphorylation decoupling targets.  
There are numerous potential applications that can be developed for controlling time- 
and environment-sensitive gene repression.  This work demonstrates that such gee 
control is possible and can increase product yields in recombinant culture.    
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